Davis Blaine
Insider CIK 1802188 · TARA Chief Financial Officer · SELB Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics, In | S Sale | 2026-01-06 | 2026-01-08 | 10,591 | $6.82 | $72.2K | 121,220 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2026-01-02 | 2026-01-06 | 109,000 | — | $0 | 109,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2026-01-02 | 2026-01-06 | 37,000 | — | $0 | 131,811 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2025-01-06 | 2025-01-07 | 4,028 | $16.83 | $67.8K | 94,811 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2025-01-03 | 2025-01-07 | 3,961 | $16.72 | $66.2K | 98,839 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2025-01-02 | 2025-01-06 | 64,600 | — | $0 | 64,600 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2025-01-02 | 2025-01-06 | 22,000 | — | $0 | 102,800 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2024-01-02 | 2024-01-04 | 3,110,000 | — | $0 | 3,110,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2024-01-02 | 2024-01-04 | 2,424,000 | — | $0 | 2,424,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 1,250,000 | $0.79 | $987.5K | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2022-11-28 | 2022-11-30 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | F Tax w/h | 2022-07-15 | 2022-07-19 | 5,081 | $3.13 | $15.9K | 20,662 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 84,800 | — | $0 | 84,800 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award | 2022-01-03 | 2022-01-05 | 14,100 | — | $0 | 15,581 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-01-19 | 2021-01-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | P Buy | 2020-09-22 | 2020-09-23 | 1,481 | $16.91 | $25.0K | 1,481 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-02-11 | 2020-02-11 | 94,000 | — | $0 | 94,000 | SEC↗ |